Glyx Therapeutics Selected as a Finalist of the i-Lab 2026 Innovation Competition
September 2026 — Amiens, France Glyx Therapeutics has been selected as a finalist of the i-Lab 2026 innovation competition, which supports the creation of deeptech companies from public research results and is backed by the France 2030 programme. Recognition for an early-stage biotech Created in December 2025, Glyx Therapeutics is developing a small molecule, administered […]
